Literature DB >> 30339473

Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.

Lily Pei-Yao Liu-Shin1,2, Adam Fung1, Arun Malhotra2, Gayathri Ratnaswamy1.   

Abstract

Antibody-drug conjugates (ADCs) that are formed using thiol-maleimide chemistry are commonly produced by reactions that occur at or above neutral pHs. Alkaline environments can promote disulfide bond scrambling, and may result in the reconfiguration of interchain disulfide bonds in IgG antibodies, particularly in the IgG2 and IgG4 subclasses. IgG2-A and IgG2-B antibodies generated under basic conditions yielded ADCs with comparable average drug-to-antibody ratios and conjugate distributions. In contrast, the antibody disulfide configuration affected the distribution of ADCs generated under acidic conditions. The similarities of the ADCs derived from alkaline reactions were attributed to the scrambling of interchain disulfide bonds during the partial reduction step, where conversion of the IgG2-A isoform to the IgG2-B isoform was favored.

Entities:  

Keywords:  ADC; IgG2; antibody-drug conjugate; conjugation process; conjugation profile; disulfide isoform; disulfide scrambling; mAb; monoclonal antibody

Mesh:

Substances:

Year:  2018        PMID: 30339473      PMCID: PMC6284598          DOI: 10.1080/19420862.2018.1521128

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  49 in total

1.  Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation.

Authors:  Yi Wang; Qiaozhen Lu; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal:  Anal Chem       Date:  2011-03-23       Impact factor: 6.986

2.  Intrachain disulfide bond in the core hinge region of human IgG4.

Authors:  J W Bloom; M S Madanat; D Marriott; T Wong; S Y Chan
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

3.  Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.

Authors:  Brian Wiggins; Lily Liu-Shin; Hideto Yamaguchi; Gayathri Ratnaswamy
Journal:  J Pharm Sci       Date:  2015-01-28       Impact factor: 3.534

Review 4.  Advances in antibody-drug conjugates: A new era of targeted cancer therapy.

Authors:  Samaresh Sau; Hashem O Alsaab; Sushil Kumar Kashaw; Katyayani Tatiparti; Arun K Iyer
Journal:  Drug Discov Today       Date:  2017-06-13       Impact factor: 7.851

5.  Tunable degradation of maleimide-thiol adducts in reducing environments.

Authors:  Aaron D Baldwin; Kristi L Kiick
Journal:  Bioconjug Chem       Date:  2011-09-26       Impact factor: 4.774

6.  Evaluation of disulfide scrambling during the enzymatic digestion of bevacizumab at various pH values using mass spectrometry.

Authors:  Wang-Chou Sung; Chiung-Wen Chang; Sheng-Yu Huang; Ting-Yu Wei; Yi-Li Huang; Yu-Hua Lin; Han-Min Chen; Sung-Fang Chen
Journal:  Biochim Biophys Acta       Date:  2016-05-27

7.  The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds.

Authors:  J Schuurman; G J Perdok; A D Gorter; R C Aalberse
Journal:  Mol Immunol       Date:  2001-01       Impact factor: 4.407

8.  Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation.

Authors:  Jianxin Guo; Sandeep Kumar; Mark Chipley; Olivier Marcq; Devansh Gupta; Zhaowei Jin; Dheeraj S Tomar; Cecily Swabowski; Jacquelynn Smith; Jason A Starkey; Satish K Singh
Journal:  Bioconjug Chem       Date:  2016-02-16       Impact factor: 4.774

Review 9.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

10.  Three-dimensional structure of the human myeloma IgG2.

Authors:  Sergey Ryazantsev; Vladimir Tischenko; Christopher Nguyen; Vyacheslav Abramov; Vladimir Zav'yalov
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

View more
  3 in total

1.  Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation.

Authors:  Susanna K Elledge; Hai L Tran; Alec H Christian; Veronica Steri; Byron Hann; F Dean Toste; Christopher J Chang; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

Review 2.  Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.

Authors:  Rahul Khetan; Robin Curtis; Charlotte M Deane; Johannes Thorling Hadsund; Uddipan Kar; Konrad Krawczyk; Daisuke Kuroda; Sarah A Robinson; Pietro Sormanni; Kouhei Tsumoto; Jim Warwicker; Andrew C R Martin
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

3.  Sensitive Immunofluorescent Detection of the PRAME Antigen Using a Practical Antibody Conjugation Approach.

Authors:  Ksenia A Sapozhnikova; Vsevolod A Misyurin; Dmitry Y Ryazantsev; Egor A Kokin; Yulia P Finashutina; Anastasiya V Alexeeva; Igor A Ivanov; Milita V Kocharovskaya; Nataliya A Tikhonova; Galina P Popova; Vera A Alferova; Alexey V Ustinov; Vladimir A Korshun; Vladimir A Brylev
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.